Vanda Pharmaceuticals (VNDA) Inventory (2012 - 2026)

Vanda Pharmaceuticals has disclosed Inventory across 15 years of filings, most recently posting $10.5 million for Q1 2026.

• Inventory for Q1 2026 came in at $10.5 million, up 2.2% year-over-year; the trailing twelve-month figure through Mar 2026 was $10.5 million (up 2.2% YoY), and the FY2025 annual result was $11.0 million, up 15.84% from the prior year.
• Inventory came in at $10.5 million for Q1 2026 at Vanda Pharmaceuticals, down from $11.0 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $11.5 million in Q4 2022 to a low of $1.1 million in Q1 2023.
• The 5-year median for Inventory is $10.0 million (2025), against an average of $7.2 million.
• Across the five-year window, Inventory surged 1020.98% in 2022 and plunged 88.19% in 2023, its largest moves.
• Vanda Pharmaceuticals' Inventory stood at $11.5 million in 2022, then slumped by 88.19% to $1.4 million in 2023, then soared by 601.03% to $9.5 million in 2024, then rose by 15.84% to $11.0 million in 2025, then slipped by 4.64% to $10.5 million in 2026.
• The last three Inventory figures came in at $10.5 million (Q1 2026), $11.0 million (Q4 2025), and $10.0 million (Q3 2025), per Business Quant data.